| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.61B | 49.33B | 43.40B | 30.17B | 20.45B | 13.66B |
| Gross Profit | 23.39B | 23.51B | 21.80B | 13.99B | 9.40B | 5.27B |
| EBITDA | 8.74B | 8.57B | 8.41B | 6.01B | 3.53B | 1.95B |
| Net Income | 5.63B | 3.02B | 5.56B | 4.14B | 2.51B | 1.24B |
Balance Sheet | ||||||
| Total Assets | 31.39B | 34.91B | 33.33B | 22.71B | 15.90B | 8.24B |
| Cash, Cash Equivalents and Short-Term Investments | 11.75B | 16.01B | 11.50B | 8.67B | 7.79B | 4.64B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 13.75B | 14.94B | 16.38B | 11.57B | 8.89B | 4.78B |
| Stockholders Equity | 17.64B | 19.96B | 16.95B | 11.14B | 7.01B | 3.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.80B | 4.66B | 1.07B | 2.50B | 3.05B |
| Operating Cash Flow | 0.00 | 7.20B | 5.29B | 4.76B | 4.87B | 3.54B |
| Investing Cash Flow | 0.00 | -2.70B | -2.70B | -3.89B | -2.76B | -793.94M |
| Financing Cash Flow | 0.00 | 0.00 | 244.00M | 0.00 | 1.04B | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥113.25B | 12.20 | 22.46% | 4.06% | -4.92% | 94.42% | |
78 Outperform | ¥57.46B | 13.64 | ― | 3.34% | 3.30% | 2.50% | |
74 Outperform | ¥52.29B | 7.81 | ― | 3.07% | -0.28% | 9.21% | |
70 Outperform | ¥39.84B | 52.83 | ― | ― | 27.05% | 495.56% | |
69 Neutral | ¥102.68B | 35.35 | ― | ― | 13.66% | -48.15% | |
63 Neutral | ¥52.70B | 26.61 | ― | 2.06% | 14.88% | 22.38% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |